COYA · Coya Therapeutics, Inc. · Executive Compensation
Market Cap
$97.12M
Shares
23.46M
Volume · Oct 23
186.43K
Avg daily vol (3M)
133.44K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Arun Swaminathan | Chief Executive Officer, Director | $2,091,007 |
| Howard Berman | Former Chief Executive Officer, Former Executive Chairman of the Board | $1,471,701 |
| Fred Grossman | President, Chief Medical Officer | $1,457,433 |
| David Snyder | Chief Financial Officer and Chief Operating Officer | $1,368,700 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Howard Berman | Former Chief Executive Officer, Current Executive Chairman of the Board | $2,680,268 |
| Fred Grossman | President, Chief Medical Officer | $1,892,438 |
| Arun Swaminathan | Chief Executive Officer, Director | $1,497,168 |
| David Snyder | Chief Financial Officer and Chief Operating Officer | $1,465,084 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Howard Berman | Former Chief Executive Officer, Current Executive Chairman of the Board | $1,317,200 |
| David Snyder | Chief Financial Officer and Chief Operating Officer | $947,888 |
| Adrian Hepner | Former President, Chief Medical Officer | $622,158 |
| Fred Grossman | President, Chief Medical Officer | $592,482 |
| Arun Swaminathan | Chief Executive Officer, Director | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Adrian Hepner | Former President, Chief Medical Officer | $726,453 |
| David Snyder | Chief Financial Officer and Chief Operating Officer | $608,521 |
| Howard Berman | Chief Executive Officer | $598,125 |
| Fred Grossman | President, Chief Medical Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Howard Berman | Chief Executive Officer | $390,000 |
| Adrian Hepner | President, Chief Medical Officer | $126,851 |
| David Snyder | Chief Financial Officer and Chief Operating Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Mark H. Pavao | independent director | Appointed | 2026-04-02 |
| Howard Berman | board of directors | Resigned | 2026-04-02 |
| Howard Berman | Executive Chairman | Resigned | 2026-04-02 |
| Dr. Hideki Garren | Board of Directors | Resigned | 2024-11-05 |
| Howard Berman | Executive Chairman | Appointed | 2024-10-31 |
| Dr. Arun Swaminathan | Chief Executive Officer | Appointed | 2024-10-31 |
| Dr. Howard Berman | Chief Executive Officer | Resigned | 2024-10-31 |
| Arun Swaminathan | Class III director | Appointed | 2024-08-19 |
| Howard Berman | Chief Executive Officer | Resigned | 2024-08-19 |
| Arun Swaminathan | Chief Executive Officer | Appointed | 2024-08-19 |
| Dov Goldstein | Class II director | Appointed | 2024-05-08 |
| Anabella Villalobos | Class II director | Appointed | 2024-05-08 |
| Wilbur L. Ross | Class I director | Appointed | 2023-12-20 |
| Dieter Weinand | Class I director | Appointed | 2023-08-21 |
| Fred Grossman | President and Chief Medical Officer | Appointed | 2023-07-10 |
| Adrian Hepner | President and Chief Medical Officer | Resigned | 2023-07-10 |
Leadership
- Arun Swaminathan CEO, Board Member
- Dr. Arun Swaminathan CEO
- Howard Berman Chairman
- David Snyder CFO, Board Member
- Anabella Villalobos Board Member
- Anabella Villalobos, Ph.D. Board Member
- Ann Lee Board Member
- Dieter Weinand Board Member
- Dov Goldstein Board Member
- Dov Goldstein, M.D., M.B.A. Board Member
- Fred Grossman Board Member
- Mark H. Pavao Board Member
- Mark Pavao Board Member
- Wilbur L. Ross Board Member
- Wilbur Ross Board Member